Cryoport, Inc. (NASDAQ:CYRX) Short Interest Update

Cryoport, Inc. (NASDAQ:CYRX) was the target of a large increase in short interest during the month of July. As of July 15th, there was short interest totalling 3,600,000 shares, an increase of 13.2% from the June 30th total of 3,180,000 shares. Based on an average daily trading volume, of 755,300 shares, the days-to-cover ratio is currently 4.8 days. Approximately 7.6% of the company’s shares are sold short.

Insider Activity at Cryoport

In related news, Director Richard J. Berman sold 8,105 shares of the firm’s stock in a transaction that occurred on Wednesday, May 15th. The shares were sold at an average price of $13.41, for a total value of $108,688.05. Following the completion of the transaction, the director now owns 100,000 shares in the company, valued at approximately $1,341,000. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. In other Cryoport news, insider Edward J. Zecchini sold 3,443 shares of the firm’s stock in a transaction that occurred on Tuesday, May 14th. The shares were sold at an average price of $13.37, for a total transaction of $46,032.91. Following the completion of the transaction, the insider now owns 60,051 shares in the company, valued at approximately $802,881.87. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Richard J. Berman sold 8,105 shares of the firm’s stock in a transaction that occurred on Wednesday, May 15th. The stock was sold at an average price of $13.41, for a total transaction of $108,688.05. Following the transaction, the director now owns 100,000 shares of the company’s stock, valued at approximately $1,341,000. The disclosure for this sale can be found here. 10.10% of the stock is owned by company insiders.

Hedge Funds Weigh In On Cryoport

A number of hedge funds have recently bought and sold shares of CYRX. Comerica Bank raised its stake in shares of Cryoport by 73.0% during the 1st quarter. Comerica Bank now owns 3,481 shares of the company’s stock worth $62,000 after purchasing an additional 1,469 shares during the period. Natixis Investment Managers International raised its stake in shares of Cryoport by 61.5% during the 4th quarter. Natixis Investment Managers International now owns 4,536 shares of the company’s stock worth $70,000 after purchasing an additional 1,727 shares during the period. Lazard Asset Management LLC raised its stake in shares of Cryoport by 294.3% during the 1st quarter. Lazard Asset Management LLC now owns 5,378 shares of the company’s stock worth $95,000 after purchasing an additional 4,014 shares during the period. SG Americas Securities LLC bought a new stake in shares of Cryoport during the 2nd quarter worth $185,000. Finally, Quest Partners LLC bought a new stake in shares of Cryoport during the 4th quarter worth $202,000. 92.90% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research firms have issued reports on CYRX. B. Riley lowered shares of Cryoport from a “buy” rating to a “neutral” rating and lowered their price target for the stock from $22.00 to $19.00 in a report on Friday, May 3rd. Jefferies Financial Group started coverage on shares of Cryoport in a research report on Thursday, April 4th. They issued a “buy” rating and a $21.00 price target for the company. Finally, Needham & Company LLC reissued a “buy” rating and issued a $18.00 price target on shares of Cryoport in a research report on Wednesday, May 8th. Four equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $19.43.

Cryoport Stock Up 3.0 %

CYRX traded up $0.26 during mid-day trading on Monday, reaching $9.07. 506,345 shares of the stock were exchanged, compared to its average volume of 590,241. The company has a debt-to-equity ratio of 0.86, a quick ratio of 10.22 and a current ratio of 10.73. The stock has a market capitalization of $446.79 million, a PE ratio of -3.67 and a beta of 1.59. The company has a 50 day moving average price of $9.01 and a two-hundred day moving average price of $13.56. Cryoport has a 1 year low of $5.32 and a 1 year high of $20.10.

Cryoport (NASDAQ:CYRX) last posted its quarterly earnings data on Tuesday, May 7th. The company reported ($0.43) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.37) by ($0.06). The firm had revenue of $54.59 million for the quarter, compared to analysts’ expectations of $58.78 million. Cryoport had a negative return on equity of 15.19% and a negative net margin of 50.17%. Cryoport’s revenue was down 13.1% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.16) earnings per share. As a group, research analysts anticipate that Cryoport will post -1.35 EPS for the current year.

About Cryoport

Cryoport, Inc provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services.